Business
Sanuwave Health to Present at Canaccord Genuity Growth Conference
EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Frank, Chief Executive Officer, will present at the 45th Annual Canaccord Genuity Growth Conference, being held August 12–13, 2025, at the InterContinental Hotel in Boston, Massachusetts. Sanuwave’s group presentation is scheduled for Wednesday, August 13, from 9:30 to 9:55 a.m. ET. In addition to the p
About this update from Sanuwave Health, Inc.
[{"type":"image","alt":"SANUWAVE Health, Inc.","displaySize":"","headline":null,"caption":"SANUWAVE Health, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":64,"url":"https://media.zenfs.com/en/globenewswire.com/fd255a24ecd09cb8a9746f28b56b9952"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/R0Ec7oP_CCF56gS7YU5zXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTkwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/fd255a24ecd09cb8a9746f28b56b9952","width":300,"height":64}},"lazy":false},{"type":"text","content":"EDEN PRAIRIE, Minn., July 22, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (NASDAQ: SNWV), a leading provider of next-generation, FDA-approved wound care products , today announced, that Morgan Frank, Chief Executive Officer, will present at the 45th Annual Canaccord Genuity Growth Conference, being held August 12–13, 2025, at the InterContinental Hotel in Boston, Massachusetts.","length":383,"tagName":"p"},{"type":"text","content":"Sanuwave’s group presentation is scheduled for Wednesday, August 13, from 9:30 to 9:55 a.m. ET. In addition to the presentation, Mr. Frank will be available for one-on-one meetings with investors throughout the conference, which can be scheduled through the Canaccord Genuity conference portal.","length":294,"tagName":"p"},{"type":"text","content":"For additional information, please contact Sanuwave investor relations at [email protected].","length":103,"tagName":"p"},{"type":"text","content":"About Sanuwave","length":14,"tagName":"p"},{"type":"text","content":"Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.","length":249,"tagName":"p"},{"type":"text","content":"Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body's normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.","length":324,"tagName":"p"},{"type":"text","content":"Forward-Looking Statements","length":26,"tagName":"p"},{"type":"text","content":"This press release may contain “forward-looking stateme...